CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 74 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $255 | -74.5% | 6,715 | +22.8% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 5,469 | +0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 5,468 | +5.5% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 5,181 | +58.5% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 3,268 | +25.1% | 0.00% | – |
| Q3 2021 | $3,000 | -50.0% | 2,612 | -31.5% | 0.00% | – |
| Q2 2021 | $6,000 | -14.3% | 3,811 | +0.0% | 0.00% | – |
| Q1 2021 | $7,000 | +133.3% | 3,810 | +30.9% | 0.00% | – |
| Q4 2020 | $3,000 | -88.0% | 2,910 | -54.1% | 0.00% | – |
| Q3 2020 | $25,000 | -65.8% | 6,334 | -28.8% | 0.00% | – |
| Q2 2020 | $73,000 | +143.3% | 8,890 | +52.9% | 0.00% | – |
| Q1 2020 | $30,000 | – | 5,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |